Epithelial/immune interactions underlying development and resolution of allergic airway inflammation and remodelling influence of genes and environment.
In plain English
AI plain-English summaryA single dust mite can trigger a cascade of immune and lung cell interactions that determines whether a person develops chronic asthma or simply sneezes and recovers. This research tackles a fundamental gap in asthma science: why some people’s lungs mount a short-lived, harmless response to allergens while others spiral into long-term inflammation and airway scarring. The team will use mouse models to track exactly how inhaled house dust mite particles interact with lung epithelial cells and immune cells, and how factors like age, viral infections, and air pollution tip the balance from tolerance to disease. They will also test the specific roles of known asthma risk genes and the signalling molecule TGFbeta in driving airway remodelling—the structural damage that makes asthma irreversible. This is fundamental science. It will not produce a new inhaler or drug tomorrow. But by mapping the precise cellular and molecular switches that govern whether inflammation resolves or persists, the work could eventually reveal new targets for therapies that prevent asthma from becoming chronic. Similar mechanistic studies of lung immunity have previously underpinned the development of biologic treatments for severe asthma.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Senior Research Fellowship Basic RenewalPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know